⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29994519 | 1.00 | — | — | |
| SCHEMBL26672080 | 0.74 | — | — | |
| SCHEMBL29662162 | 0.74 | — | — | |
| SCHEMBL29770643 | 0.72 | — | — | |
| SCHEMBL29479476 | 0.72 | — | — | |
| SCHEMBL423090 | 0.72 | — | — | |
| SCHEMBL15004521 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL28430002 | 0.70 | — | — | |
| Ammonia Solution, Strong SCHEMBL20338348 | 0.70 | — | — | |
| Ammonia Solution, Strong SCHEMBL18227036 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107435043-A | Based on the polycarbonate modified functional material for being used to fix thimet degradation bacteria | 光合强化（北京）生物科技有限公司 | 2017-12-05 | — | — | CN | claimed |
| EP-0072299-B1 | 4-METHYL-6-PHENYL-PYRIDAZINE DERIVATIVES ACTIVE ON THE CENTRAL NERVOUS SYSTEM | SANOFI S.A. (FR) | 1986-12-17 | — | — | EP | claimed |
| US-20260132121-A1 | INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF | ODYSSEY THERAPEUTICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-12624018-B1 | Inhibitors of RIPK2 and medical uses thereof | ODYSSEY THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260116868-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | ARCUS BIOSCIENCES, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4720055-A1 | CBL-B INHIBITORS AND METHODS OF USE THEREOF | Arcus Biosciences, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| CN-121758397-A | Method for synthesizing piperazine-N, N' -bis (2-hydroxy propane sulfonic acid) dihydrate | 济宁亚科新材料科技有限公司 | 2026-03-31 | — | — | CN | disclosed |
| CN-121758397-A | Method for synthesizing piperazine-N, N' -bis (2-hydroxy propane sulfonic acid) dihydrate | 济宁亚科新材料科技有限公司 | 2026-03-31 | — | — | CN | disclosed |
| US-12509431-B2 | 1,4-dihydroquinazolinone compounds and uses thereof | EDGEWISE THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250361213-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| WO-2025227032-A1 | METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES | REMIX THERAPEUTICS INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| CN-1741999-A | Pyridazinone derivatives as GSK-3 beta inhibitors | AVENTIS PHARMA GMBH (DE) | 2006-03-01 | — | — | CN | disclosed |
| EP-1597261-A1 | SUBSTITUTED AMINO HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LTD. (GB) | 2005-11-23 | — | — | EP | disclosed |
| CN-1636996-A | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands | ABBOTT LAB (US) | 2005-07-13 | — | — | CN | disclosed |
| WO-2005007648-A2 | BIARYL PIPERAZINYL-PYRIDINE ANALOGUES | NEUROGEN CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |
| WO-2004074290-A1 | SUBSTITUTED AMINO HETEROCYCLES AS VR-1 ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LIMITED (GB) | 2004-09-02 | — | — | WO | disclosed |
| CN-1345320-A | Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands | ABBOTT LAB (US) | 2002-04-17 | — | — | CN | disclosed |
| CN-1057295-C | Sulfonamide endothelin antagonists | BRISTOL MYERS SQUIBB CO (US) | 2000-10-11 | — | — | CN | disclosed |
| CN-1251589-A | Substituted triazolopyridazine derivatives as ligands for GABA receptors | MERCK SHARP & DOHME (GB) | 2000-04-26 | — | — | CN | disclosed |
| CN-1106805-A | Sulfonamide endothelin antagonists | BRISTOL MYERS SQUIBB CO (US) | 1995-08-16 | — | — | CN | disclosed |